</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
{{custommediaemailsadvanced::brand_color}} {{custommediaemailsadvanced::brand_secondary_color}} {{custommediaemailsadvanced::eyebrow_copy}} {{custommediaemailsadvanced::eyebrow_background_color}} {{custommediaemailsadvanced::eyebrow_text_color}} {{custommediaemailsadvanced::is_partner_podcast}} Or listen on your favorite{nbs}platform: {{custommediaemailsadvanced::partner_podcast_spotify_url}} {{custommediaemailsadvanced::partner_podcast_apple_url}} {{custommediaemailsadvanced::partner_podcast_google_url}} /uploads/nutramax_c_n_avmaquin_email_sponsor_logo_2_x-d31172b26f0e1e313d4fdfe8242a3614.jpg {{custommediaemailsadvanced::logo_self_hosted}} 134 {{custommediaemailsadvanced::logo_height}} {{custommediaemailsadvanced::logo_padding}} {{custommediaemailsadvanced::logo_alt_text}} {{custommediaemailsadvanced::logo_url}} {{custommediaemailsadvanced::no_border_under_logo}} {{custommediaemailsadvanced::apply_logo_over_background_image}} true /uploads/nutramax_c_n_avmaquin_eblast_header_2_x-d6ee6cc6cedc588fb3f2aa55e771af63.jpg {{custommediaemailsadvanced::desktop_header_image_alt}} {{custommediaemailsadvanced::desktop_header_image_alt_1x}} true true {{custommediaemailsadvanced::mobile_header_image}} {{custommediaemailsadvanced::mobile_header_image_alt}} {{custommediaemailsadvanced::add_left_right_padding_to_header_image}} {{custommediaemailsadvanced::add_bottom_padding_to_header_image}} {{custommediaemailsadvanced::add_top_padding_to_header_image}} {{custommediaemailsadvanced::header_image_padding_background_color}} {{custommediaemailsadvanced::scale_mobile_header_image}} {{custommediaemailsadvanced::background_height}} #000000 {{custommediaemailsadvanced::headline_image}} {{custommediaemailsadvanced::headline_image_self_hosted}} {{custommediaemailsadvanced::headline_url}} 480 379 {{custommediaemailsadvanced::headline_image_custom_css}} {{custommediaemailsadvanced::place_headline_image_above_header_image}} {{custommediaemailsadvanced::place_headline_image_below_header_image}} {{custommediaemailsadvanced::spacer_image}} {{custommediaemailsadvanced::spacer_image_self_hosted}} 600 {{custommediaemailsadvanced::spacer_image_height}} {{custommediaemailsadvanced::spacer_image_scale_desktop_padding_bottom}} {{custommediaemailsadvanced::spacer_image_scale_mobile_padding_bottom}} {{custommediaemailsadvanced::subhead_copy}} {{custommediaemailsadvanced::large_subhead_copy}} {{custommediaemailsadvanced::subhead_td_custom_css}} {{custommediaemailsadvanced::subhead_span_custom_css}} {{custommediaemailsadvanced::horizontal_rule_under_subhead}} {{custommediaemailsadvanced::intro_copy}} {{custommediaemailsadvanced::intro_centered}} {{custommediaemailsadvanced::intro_copy_td_custom_css}} {{custommediaemailsadvanced::intro_copy_span_custom_css}} {{custommediaemailsadvanced::horizontal_rule_under_intro}}

Transitional cell carcinoma appears to be increasing in prevalence, and standard detection methods have historically been invasive and costly. A new molecular approach is available to noninvasively aid in detecting TCC and screen predisposed breeds. Earlier detection could increase the time for appropriate intervention and potentially improve patient outcomes and quality of life. 

{{custommediaemailsadvanced::custom_body_text_color}} {{custommediaemailsadvanced::custom_body_background_color}} padding-bottom: 60px; {{custommediaemailsadvanced::body_span_custom_css}} {{custommediaemailsadvanced::custom_body_horizontal_rule_color}} {{custommediaemailsadvanced::ordered_list_bullet_1}} 1 {{custommediaemailsadvanced::custom_icon_1}} {{custommediaemailsadvanced::custom_icon_1_self_hosted}} {{custommediaemailsadvanced::custom_icon_1_width}} {{custommediaemailsadvanced::ordered_list_bullet_2}} 2 {{custommediaemailsadvanced::custom_icon_2}} {{custommediaemailsadvanced::custom_icon_2_self_hosted}} {{custommediaemailsadvanced::custom_icon_2_width}} {{custommediaemailsadvanced::ordered_list_bullet_3}} 3 {{custommediaemailsadvanced::custom_icon_3}} {{custommediaemailsadvanced::custom_icon_3_self_hosted}} {{custommediaemailsadvanced::custom_icon_3_width}} {{custommediaemailsadvanced::ordered_list_bullet_4}} 4 {{custommediaemailsadvanced::custom_icon_4}} {{custommediaemailsadvanced::custom_icon_4_self_hosted}} {{custommediaemailsadvanced::custom_icon_4_width}} {{custommediaemailsadvanced::ordered_list_bullet_5}} 5 {{custommediaemailsadvanced::custom_icon_5}} {{custommediaemailsadvanced::custom_icon_5_self_hosted}} {{custommediaemailsadvanced::custom_icon_5_width}} #000000 {{custommediaemailsadvanced::center_icons_in_mobile}} {{custommediaemailsadvanced::ordered_list_bullet_td_custom_css}} {{custommediaemailsadvanced::ordered_list_bullet_span_custom_css}} {{custommediaemailsadvanced::body_2_copy}} {{custommediaemailsadvanced::body_2_td_custom_css}} {{custommediaemailsadvanced::body_2_span_custom_css}} {{custommediaemailsadvanced::closing_emphasis_copy}} {{custommediaemailsadvanced::closing_emphasis_link_text}} {{custommediaemailsadvanced::closing_emphasis_link_url}} {{custommediaemailsadvanced::closing_emphasis_link_color}} {{custommediaemailsadvanced::closing_emphasis_td_custom_css}} {{custommediaemailsadvanced::closing_emphasis_span_custom_css}} background: #e4e4e3 Read up on the latest in the{br}detection of TCC and sulforaphane{br}in this clinical{nbs}update. #002965 true {{custommediaemailsadvanced::cta_line_2}} {{custommediaemailsadvanced::cta_line_2_custom_text_color}} {{custommediaemailsadvanced::cta_line_2_link}} Get the scoop #002965 {{custommediaemailsadvanced::custom_button_text_color}} https://www.cliniciansbrief.com/article/clinical-notes-canine-transitional-cell-carcinoma-whats-new {{custommediaemailsadvanced::footnote}} {{custommediaemailsadvanced::large_footnote_copy}} {{custommediaemailsadvanced::footnote_td_custom_css}} {{custommediaemailsadvanced::footnote_span_custom_css}} {{custommediaemailsadvanced::pre_footer_copy}} {{custommediaemailsadvanced::pre_footer_center}}
Canine Transitional Cell Carcinoma
{{custommediaemailsadvanced::logo_alt_text}}
{{custommediaemailsadvanced::headline}}

Transitional cell carcinoma appears to be increasing in prevalence, and standard detection methods have historically been invasive and costly. A new molecular approach is available to noninvasively aid in detecting TCC and screen predisposed breeds. Earlier detection could increase the time for appropriate intervention and potentially improve patient outcomes and quality of life. 

Read up on the latest in the{br}detection of TCC and sulforaphane{br}in this clinical{nbs}update.
{{custommediaemailsadvanced::cta_line_2}}
Get the scoop
{{custommediaemailsadvanced::logo_alt_text}}
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
Canine Transitional Cell Carcinoma
{{custommediaemailsadvanced::logo_alt_text}}
{{custommediaemailsadvanced::headline}}

Transitional cell carcinoma appears to be increasing in prevalence, and standard detection methods have historically been invasive and costly. A new molecular approach is available to noninvasively aid in detecting TCC and screen predisposed breeds. Earlier detection could increase the time for appropriate intervention and potentially improve patient outcomes and quality of life. 

Read up on the latest in the{br}detection of TCC and sulforaphane{br}in this clinical{nbs}update.
{{custommediaemailsadvanced::cta_line_2}}
Get the scoop
{{custommediaemailsadvanced::logo_alt_text}}